drugset

drugset / Trial / NCT00212706

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212706 ↗

Phase 2 Completed 400 enrolled Ono Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.

Timeline

Start: 2001-10
Primary completion: 2002-11
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imidafenacin	Small molecule	—	—

Indications